News Coverage 10.22.19 By: Molika Ashford Share on Twitter Share on Facebook Share on LinkedIn Q&A: The Parker Institute’s Theresa LaVallee on the Path Forward for Precision Immuno-Oncology Related Announcement, Press Release PICI Invests $1 Million+ in 5 Early Career Researchers Announcement, Patient Story Living Proof: Cancer Vaccine Recipients Bring Their Sto Research Update Cancer Vaccines: A New Era in Cancer Treatment